Mitotic Count and Estimation of the Risk of GIST Recurrence in Patients Treated With Preoperative Imatinib

Clinical Oncology and Research

doi 10.31487/j.cor.2019.5.15

Full Text

Abstract

Available in

Date

December 30, 2019

Authors

Mikael Eriksson

Heikki Joensuu

Mikael Eriksson

Publisher

Science Repository OU

Related search

Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib

Cancer Chemotherapy and Pharmacology

English

The Economic Burden of Gastrointestinal Stromal Tumor (GIST) Recurrence in Patients Who Have Received Adjuvant Imatinib Therapy

Journal of Medical Economics

Health Policy

2014

English

Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

PLoS ONE

Multidisciplinary

2012

English

Dramatic Regression and Bleeding of a Duodenal GIST During Preoperative Imatinib Therapy: Case Report and Review

World Journal of Surgical Oncology

Surgery

Oncology

2010

English

Prediction of Risk of Disease Recurrence by Genome-Wide cDNA Microarray Analysis in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated With Imatinib-Combined Chemotherapy

International Journal of Oncology

Cancer Research

Oncology

2007

English

Surgical Treatment of Meningiomas - Outcome Associated With Type of Resection, Recurrence, Karnofsky Performance Score, Mitotic Count

Open Access Macedonian Journal of Medical Sciences

Medicine

2019

English

Neoadjuvant Imatinib for Borderline Resectable GIST

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2012

English

The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib

English

Local Recurrence After Surgery of Locally Advanced Rectal Cancer Treated With or Without Preoperative Chemoradiotherapy

English

Amanote Research

Mitotic Count and Estimation of the Risk of GIST Recurrence in Patients Treated With Preoperative Imatinib

Clinical Oncology and Research

Full Text

Abstract

Date

Authors

Publisher

Related search

Evaluation of Nilotinib in Advanced GIST Previously Treated With Imatinib and Sunitinib

The Economic Burden of Gastrointestinal Stromal Tumor (GIST) Recurrence in Patients Who Have Received Adjuvant Imatinib Therapy

Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

Dramatic Regression and Bleeding of a Duodenal GIST During Preoperative Imatinib Therapy: Case Report and Review

Prediction of Risk of Disease Recurrence by Genome-Wide cDNA Microarray Analysis in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated With Imatinib-Combined Chemotherapy

Surgical Treatment of Meningiomas - Outcome Associated With Type of Resection, Recurrence, Karnofsky Performance Score, Mitotic Count

Neoadjuvant Imatinib for Borderline Resectable GIST

The EUTOS Prognostic Score: Review and Validation in 1288 Patients With CML Treated Frontline With Imatinib

Local Recurrence After Surgery of Locally Advanced Rectal Cancer Treated With or Without Preoperative Chemoradiotherapy